Literature DB >> 7438409

Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation.

M Naito, E L Michelson, J J Kmetzo, E Kaplinsky, L S Dreifus.   

Abstract

Ninety-nine adult mongrel dogs underwent acute ligation of the proximal left anterior descending coronary artery. Thirty minutes later, the occlusion was released to evaluate the effectiveness of five antiarrhythmic protocols in eliminating reperfusion ventricular fibrillation. The five protocols included: protocol 1 --i.v. lidocaine, preligation and prerelease (n = 19); protocol 2 -- i.v. lidocaine, prereperfusion only (n = 22); protocol 3 -- chronic, oral, daily amiodarone for 2 weeks preligation (n = 19); protocol 4 -- i.v. procainamide, preligation and prereperfusion (n = 21); and protocol 5 -- i.v. verapamil, prereperfusion (n = 18). Each regimen was evaluated with respect to the incidence of reperfusion ventricular fibrillation in dogs that survived to reperfusion, and the results were compared to 77 control dogs that underwent identical coronary artery occlusion and release procedures without drug therapy. The incidence of reperfusion ventricular fibrillation was as follows: protocol 1 -- seven of 15 dogs (47%); protocol 2 -- six of 18 (33%); protocol 3 -- 11 of 16 dogs (69%); protocol 4 -- eight of 17 dogs (47%); and protocol 5 -- 10 of 17 dogs (59%), compared with 36 of 60 (60%) in control dogs. Using chi-square analysis, protocol 2 was beneficial (p < 0.05). The dogs were then stratified into high- and low-risk subgroups based on the arrhythmic events of the antecedent coronary artery ligation periods, and predictive risk indexes for the occurrence of reperfusion ventricular fibrillation were developed. the Mantel-Haenszel method of statistical analysis revealed that none of these protocols resulted in a statistically significant reduction in the incidence of reperfusion ventricular fibrillation. Thus, use of these predictive indexes plus appropriate statistical methods has revealed, unexpectedly, limitations in the efficacy of a spectrum of antiarrhythmic agents in preventing reperfusion ventricular fibrillation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7438409     DOI: 10.1161/01.cir.63.1.70

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  Role of calcium ions in reperfusion arrhythmias: relevance to pharmacologic intervention.

Authors:  L H Opie; W A Coetzee
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

2.  What is the solution to sudden cardiac death: calcium modulation or arrhythmia clinics?

Authors:  W T Clusin
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

3.  [Arrhythmia as an indicator for reperfusion following acute myocardial infarct?].

Authors:  K Langes; W Bleifeld; D G Mathey; K H Kuck
Journal:  Klin Wochenschr       Date:  1989-12-04

4.  An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents.

Authors:  K A Kane; J R Parratt; F M Williams
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

5.  Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds.

Authors:  S J Coker; J R Parratt
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

6.  Effect of magnesium on ischemic and reperfusion arrhythmias in a canine model with diminished collateral blood flow.

Authors:  D E Euler
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

7.  Protective effects of bradykinin on the ischaemic heart: implication of the B1 receptor.

Authors:  R Chahine; A Adam; N Yamaguchi; R Gaspo; D Regoli; R Nadeau
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

8.  Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs.

Authors:  B G Benfey; M S Elfellah; R I Ogilvie; D R Varma
Journal:  Br J Pharmacol       Date:  1984-07       Impact factor: 8.739

9.  Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.

Authors:  H Gülker; W Haverkamp; G Hindricks; F Bender
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

10.  Prolonged ursodeoxycholic acid administration reduces acute ischaemia-induced arrhythmias in adult rat hearts.

Authors:  Elisa Ferraro; Lidia Pozhidaeva; David S Pitcher; Catherine Mansfield; Jia Han Benjamin Koh; Catherine Williamson; Oleg Aslanidi; Julia Gorelik; Fu Siong Ng
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.